Induction of hepatocellular proliferative lesions in CBA mice by a 26-week dietary administration of Kojic acid

Journal of Toxicologic Pathology

Volumn 18, Issue 3, 2005, Pages 159-165

  Watanabe, Takao ^a   Mori, Taeko ^a   Okamura, Miwa ^a   Kashida, Yoko ^a   Mitsumori, Kunitoshi ^a  

^a TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Japan)

Author keywords

CBA mouse; Kojic acid; Live proliferative lesion induction

Indexed keywords

EID: 27744483511     PISSN: 09149198     EISSN: None     Source Type: Journal    
DOI: 10.1293/tox.18.159     Document Type: Article

References (21)

1. Parrish FW, Wiley BJ, Simmons EG, and Long LJr. Production of aflatoxins and kojic acid by species of Aspergillus and Penicillium. Appl Microbiol. 14: 136-139. 1966.
2. Kwak MY and Rhee JS. Cultivation characteristics of immobilized Aspergillus oryzae for kojic acid production. Biotechnol Bioeng. 39: 903-906. 1992.
3. Saruno R, Kato F, and Ikeno T. Kojic acid, a tyrosinase inhibitor from Aspergillus albus. Agric Biol Chem. 43: 1337-1338. 1979.
4. Chen JS, Wei CI, Rolle RS, Otwell WS, Balaban MO, and Marshall MR. Inhibitory effects of kojic acid on some plant and crustacean polyphenol oxidases. J Agric Food Chem. 39: 1396-1401. 1991.
5. Kahn V. Effect of kojic acid on the oxidation of DL-DOPA, norepinephrine and dopamine by mushroom tyrosinase. Pigment Cell Res. 8: 234-240. 1995.
6. Ohyama Y. Melanogenesis-inhibitory effect of kojic acid and its action mechanism. Fragrance J. 6: 53-58. 1990.
7. Perez-Bernal A, Munoz-Perez MA, and Camacho F. Management of facial hyperpigmentation. Am J Clin Dermatol. 1: 261-268. 2000.
8. Maeda K, and Fukuda M. In vitro effectiveness of several whitening cosmetic components in human melanocytes. J Soc Cosmet Chem. 42: 361-368. 1991.
9. Fujimoto N, Watanabe H, Nakatani T, Roy G, and Ito A. Induction of thyroid tumors in (C57BL/6N×C3H/N)F1 mice by oral administration of kojic acid. Food Chem Toxicol. 36: 697-703. 1998.
10. Takizawa T, Mitsumori K, Tamura T, Nasu M, Ueda M, Imai T, and Hirose M. Hepatocellular tumor induction in heterozygous p53-deficient CBA mice by a 26-week dietary administration of kojic acid. Toxicol Sci. 73: 287-293. 2003.
11. Uehara T, Kashida Y, Watanabe T, Yasuhara K, Onodera H, Hirose M, and Mitsumori K. Susceptibility of liver proliferative lesions in heterozygous p53 deficient CBA mice to various carcinogens. J Vet Med Sci. 64: 551-556. 2002.
12. Smith GS, Walford RL, and Mickey RM. Lifespan and incidence of cancer and other diseases in selected long-lived inbred mice and their F1 hybrids. J Natl Cancer Inst. 50: 1195-1213. 1973.
13. Shibuya T, Murata T, Sakamoto K, Iwahara S, and Ikeno M. Mutagenicity and dominant lethal test of kojic acid. Toxicol Sci. 7: 255-262. 1982.
14. Wei CI, Huang TS, Fernando SY, and Chung KT. Mutagenicity studies of kojic acid. Toxicol Lett. 59: 213-220. 1991.
15. Ishidate MJr, Harnois MC, and Sofuni T. A comparative analysis of data on the clastogenicity of 951 chemical substances tested in mammalian cell cultures. Mutat Res. 195: 151-213. 1988.
16. Watanabe T, Mori T, Kitamura Y, Umemura T, Okamura M, Kashida Y, Nishikawa A, Hirose M, and Mitsumori K. Lack of initiating activity of kojic acid on hepatocarcinogenesis in F344 rats. J Toxicol Pathol. 18: 79-84. 2005.
17. Dunnett CW. A multiple comparison procedure for comparing several treatments with a control. J Am Stat Assoc. 50: 1096-1121. 1955.
18. Takizawa T, Imai T, Onose J, Ueda M, Tamura T, Mitsumori K, Izumi K, and Hirose M. Enhancement of hepatocarcinogenesis by kojic acid in rat two-stage models after initiation with N-bis(2-hydroxypropyl)nitrosamine or N-diethylnitrosamine. Toxicol Sci. 81: 43-49. 2004.
19. Kinoshita R, Ishino T, Sugiyama S, Set T, Igarashi S, and Goetz IE. Mycotoxins in fermented food. Cancer Res. 28: 2296-2311. 1968.
20. Stark AA. Mutagenicity and carcinogenicity of mycotoxins: DNA binding as a possible mode of action. Annu Rev Microbiol. 34: 235-262. 1980.
21. Sakai H, Tsukamoto T, Yamamoto M, Kobayashi K, Yuasa H, Imai T, Yanai T, Masegi T, and Tatematsu M. Distinction of carcinogens from mutagens by induction of liver cell foci in a model for detection of initiation activity. Cancer Lett. 188: 33-38. 2002.